English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

MBI sales up 2% in Q1 2014qrcode

May. 16, 2014

Favorites Print
Forward
May. 16, 2014

The US biopesticide company Marrone Bio Innovations (MBI) recorded a 2.2% increase in sales to around $2.8 million in the first quarter of 2014. Product sales decreased by 11.6% to some $ 2.1 million in this quarter, while related party revenues grew by some 110% to $309,000. Licensing revenues dropped by 6.3% to $45,000. The result is in line with the company's expectations against the headwinds of severe weather in all growing regions, the company notes.

MBI's sales results($ 000)
Q1 ended Mar 31
Q1 2014
Q1 2013
% change
Revenues
2,790
2,730
+2.2
Products
2,097
2,373
-11.6
Licensing
45
48
-6.3
Related party
648
309
109.7
Gross profit
1,138
935
+21.7
Net profit (loss)
(10,246)
(10,749)
-

MBI recorded a 21.7% rise in gross profit to around $1.1 million. The company registered a net loss of $10.2 million versus a loss of $10.7 million in the first quarter of 2013.

For the full year 2014 the Company continues to expect net revenues to at least double compared to the full year 2013. The company also expects to launch at least 1-2 new products in addition to its insecticide Venerate.

 

0/1200

More from AgroNewsChange

Hot Topic More

Subscribe Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe BioEx Biweekly to send news related to your mailbox